The Corporate Reputation of Pharma 2015 - The Perspective of 111 Patient Groups with an Interest in Hepatitis

  • ID: 3942956
  • Report
  • 45 pages
  • PatientView
1 of 4

FEATURED COMPANIES

  • AbbVie
  • B-MS
  • Gilead Sciences
  • Janssen
  • Novartis
  • Roche
  • MORE

This report is based on the findings of a November 2015-January 2016 survey exploring the views of 111 patient groups with an interest in hepatitis worldwide. The report provides feedback on the corporate reputation of the pharma industry during 2015, from the perspective of these patient groups, as well as the performance of 14 pharma companies for six key indicators that influence corporate reputation. Results are compared with those attained across all therapy areas in 2015.

“I think that scenarios such as the exorbitant cost of hepatitis-C drugs have perpetuated the notion of industry only caring about shareholders and profits above patient satisfaction, or even caring to offer access to life-saving medications.”  —Regional Canada-based patient group specialising in hepatitis, HIV/AIDS, and sexual health                                   

Profiles Of the 14 Companies, According To the Skin Patient Groups Familiar with These Companies, or Have Worked With Them

Each profile contains

Company Background Information

  •     Annual revenue (latest-available year), comprising amount in currency, as quoted by the profiled company itself. Increase in revenue over the previous year or decrease in revenue.
  •     The profiled company’s main treatment subject areas (and areas of R&D).
  •     A mission statement from the profiled company.

How the Company Has Performed At Six Indicators of Corporate Reputation

  •  The profiled company’s performance at the six indicators of corporate reputation in 2015, according to the skin patient groups familiar with the company.
  •  The profiled company’s performance at the six indicators of corporate reputation, according to the neurological patient groups that have worked with the company.
  •  How the profiled company performed among neurological patient groups for different countries/regions, compared with the company’s global averages for neurological patient groups in 2015.

How the Company Ranks For Corporate Reputation Compared With Other Companies

  •  The profiled company’s rankings among skin patient groups in 2015 for the six indicators of corporate reputation, compared with 13 other companies.
  •  The profiled company’s rankings worldwide in 2015 for the six indicators of corporate reputation, compared with 47 other companies.

Profile of The Patient Groups Familiar With The Company

  •  Other companies that partner with a significant number of the profiled company’s partner patient groups.
  •  The countries of the patient groups familiar with the profiled company.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie
  • B-MS
  • Gilead Sciences
  • Janssen
  • Novartis
  • Roche
  • MORE

ABOUT THIS REPORT 

WHAT DID HEPATITIS PATIENT GROUPS SAY ABOUT PHARMA IN 2015?

  •  Summary of the industry-wide findings (as judged by hepatitis patient groups)

 SOME POINTS ABOUT THE HEPATITIS CORPORATE RANKINGS 

WHAT CAN PHARMA COMPANIES DO TO IMPROVE THEIR CORPORATE REPUTATION?

COMMENTS FROM HEPATITIS PATIENT GROUPS, 2015 

METHODOLOGY OF THE PATIENT-GROUP SURVEY 

APPENDIX 1: Data on how hepatitis patient groups see the pharmaceutical industry in 2015
APPENDIX 2: Rankings of the 14 pharma companies for each of the six indicators of corporate reputation, as perceived by hepatitis patient groups in 2015
APPENDIX 3: Profiles of the 14 pharma companies, as perceived by hepatitis patient groups in 2015
APPENDIX 4: Profile of the 111 respondent hepatitis patient groups

LIST OF TABLES AND CHARTS—BASED ON THE VIEWS OF HEPATITIS PATIENT GROUPS, 2015
 Percentage of hepatitis patient groups claiming familiarity with the company 
 Percentage of hepatitis patient groups claiming familiarity with the company, and which also worked with it  
 Percentage of patient groups worldwide (by therapy area) stating that pharma is “Excellent” or “Good” at BEING INNOVATIVE
 Percentage of patient groups worldwide (by therapy area) stating that pharma is “Excellent” or “Good” at PROVIDING HIGH-QUALITY PRODUCTS
 Percentage of patient groups worldwide (by therapy area) stating that pharma is “Excellent” or “Good” at HAVING FAIR PRICING POLICIES
 Percentage of patient groups worldwide (by therapy area) stating that pharma is “Excellent” or “Good” at BEING TRANSPARENT
 Final overall rankings, hepatitis, 2015 
 If a pharma company wishes to improve its corporate reputation with patients and patient groups, which single strategy from the list below do you think would be MOST IMPORTANT for the company to follow?
 What patient groups from 12 therapy areas thought of the importance of fair pricing to corporate reputation 
 How do you think your organisation’s members (or the people you represent) would rate the corporate reputation of the following healthcare sectors in 2015?
What do you think has happened to the corporate reputation of the pharma industry over the past five years? 
How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)?
 How good or bad do you think the pharma industry is in 2015 at carrying out the following activities (all of which influence their corporate standing with patients and patient groups)?
 Companies with the most effective patient-centred strategy (rankings of 14 companies, 2015) 
 Companies providing the best high-quality patient information (rankings of 14 companies, 2015) 
 Companies with the best record on patient safety (rankings of 14 companies, 2015) 
 Companies with the most-useful high-quality products (rankings of 14 companies, 2015) 
 Companies with the best record of transparency (rankings of 14 companies, 2015) 
 Companies with the best record on integrity (rankings of 14 companies, 2015) 
 Rankings of the 14 pharmaceutical companies in 2015, ALPHABETIC ORDER 
 Rankings of the 14 pharmaceutical companies in 2015, HIGHEST TO LOWEST 
 Profile of 111 respondent patient groups with an interest in hepatitis (2015), by country 
 Profile of 111 respondent patient groups with an interest in hepatitis (2015), geographic remit

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AbbVie
  • B-MS
  • Bayer
  • Boehringer Ingelheim
  • GSK
  • Gilead Sciences
  • Janssen
  • Merck & Co (US)
  • Novartis
  • Pfizer
  • Roche
  • Sandoz
  • Sanofi
  • ViiV Healthcare
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll